Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Lawmakers Grill Turing, Valeant Over Drug Price Increases

February 4, 2016 11:36 am | by Ryan Bushey, Associate Editor | News | Comments

Martin Shkreli and Valeant CEO Howard Schiller were questioned about their companies' actions for new drugs. Read more...

TOPICS:

U.S. Zika Case Sparks Questions About Sex and Mosquito Germs

February 4, 2016 11:27 am | by Mike Stobbe, AP Medical Writer | News | Comments

A sexually transmitted case of Zika in Texas has scientists scrambling to understand how much of a risk infection through sex is for the usually mosquito-spread illness. Read more..

TOPICS:

Draper Device Could Help Develop Drugs for Hearing Loss

February 4, 2016 11:03 am | by betaBoston | News | Comments

A battery-operated device a little larger than a golf ball could one day help treat people with hearing loss by delivering medication directly into the cavity in their ear. Read more..

TOPICS:
Advertisement

WATCH: Martin Shkreli's Congressional Hearing on Drug Prices

February 4, 2016 10:58 am | by Ryan Bushey, Associate Editor | Videos | Comments

The controversial executive plans on pleading the fifth during the hearing. Watch here.

TOPICS:

The Future of Medicine Could be Found in This Tiny Crystal Ball

February 4, 2016 10:52 am | by Drexel University | News | Comments

​A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body. Read more...

TOPICS:

Johnson & Johnson, Viacyte Testing Possible Diabetes Cure

February 4, 2016 10:45 am | by Linda A. Johnson, AP Business Writer | News | Comments

Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix the life-threatening hormonal disorder. Read more...

TOPICS:

Diabetes Discovery Could Lead to More Effective Drugs

February 4, 2016 8:33 am | by University of Melbourne | News | Comments

The formation of type 2 diabetes is directly related to how our muscles convert sugar, a landmark new study has found. Researchers at the University of Melbourne's Medical School at the Austin Hospital have used elegant gene splicing technology to prove this popular theory about the biological cause of Type 2 diabetes. Read more...

TOPICS:

New Insights into Function of Main Class of Drug Targets

February 4, 2016 8:32 am | by University of Basel | News | Comments

A wide variety of drugs such as beta-blockers against high blood pressure or drugs against allergies, cancer, Parkinson's disease, HIV and others bind to cell surface proteins which belong to the family of G protein coupled receptors. Read more...

TOPICS:
Advertisement

GSK Posts Loss as it Integrates New Businesses

February 4, 2016 8:32 am | by Danica Kirka, The Associated Press | News | Comments

Drugmakers like GSK have been trying to focus on strengths amid competition from generic drugmakers. Read more...

TOPICS:

EU Approves AstraZeneca's Lung Cancer Drug

February 4, 2016 8:31 am | News | Comments

Mutations in the EGFR receptor can lead to uncontrolled cell growth and tumor formation. Read more...

TOPICS:

Aspirin Could Reduce Risk of Staph Blood Infections

February 4, 2016 8:30 am | by Ryan Bushey, Associate Editor | News | Comments

Aspirin has been previously linked to lowering risk of various heart conditions. Read more...

TOPICS:

BMJ Investigation Casts Doubt on Validity of Rivaroxaban Trial

February 4, 2016 8:30 am | by Stephanie Guzowski, Editor | News | Comments

New questions have been raised about the validity and reliability of data in the ROCKET-AF trial, which serves as the backbone for the approval of rivaroxaban (Xarelto), according to an investigation published Wednesday by The BMJ. Rivaroxaban is a blockbuster drug for stroke prevention in atrial fibrillation (AF) that gained approval from both U.S. and European regulators. Read more...

TOPICS:

Several Blockbuster Drugs to Arrive This Year as Prescription Prices Rise

February 3, 2016 10:43 am | by Ryan Bushey, Associate Editor | Articles | Comments

Liver disease and HIV therapies are cited as the leading treatments. Read more...

TOPICS:

Case of Sexually Transmitted Zika is Confirmed in Texas

February 3, 2016 9:52 am | by Jamie Stengle, Associated Press | News | Comments

Health officials say a person in Texas has become infected with the Zika virus through sex, in the first case of the illness being transmitted within the United States amid the current outbreak in Latin America. Read more...

TOPICS:

New Drug Target for Rett Syndrome

February 3, 2016 9:46 am | by Harvard University | News | Comments

Harvard Stem Cell Institute (HSCI) researchers have identified a faulty signaling pathway that, when corrected, in mice ameliorates the symptoms of Rett syndrome, a devastating neurological condition. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading